Cagrilintide-RUO 10mg is a potential a groundbreaking new treatment for type 2 diabetes. This novel non-selective amylin receptor agonist works by mimicking the effects of natural amylin, a hormone produced in the pancreas that controls blood sugar levels. Cagrilintide-RUO 10mg has shown encouraging results in clinical trials, demonstrating signifi